Skip to main content

Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer

Journal of Neuro-Oncology volume 124, pages 421–427 (2015)Cite this article

Abstract

Leptomeningeal disease (LMD) is a highly aggressive and usually rapidly fatal condition. The purpose of this study is to identify clinical factors that can serve to predict for LMD at the time of stereotactic radiosurgery (SRS) for brain metastases from breast carcinoma. We conducted a retrospective review of patients with brain metastases from breast cancer treated with SRS from 1995 to 2014 at our institution. Clinical, radiographic, and dosimetric data were collected. LMD was diagnosed by cerebrospinal fluid (CSF) cytology or MRI demonstrating CSF seeding. Comparative statistical analyses were conducted using Cox proportional hazards regression, binary logistic regression, and/or log-rank test. 126 patients met inclusion criteria. Eighteen patients (14 %) developed LMD following SRS. From the time of SRS, the actuarial rate of LMD at 12 months from diagnosis of brain metastasis was 9 % (11 patients). Active disease in the chest at the time of SRS was associated with development of LMD (p = 0.038). Factors including receptor status, tumor size, number of intra-axial tumors, cystic tumor morphology, prior WBRT, active bone metastases, and active liver metastases were not significantly associated with the development of LMD. In patients with brain metastasis from breast cancer that undergo SRS, there is a relatively low rate of LMD. We found that while tumor hormonal status, bone metastases, and hepatic metastases were not associated with the development of LMD, active lung metastases at SRS was associated with LMD. Further research may help to delineate a causative relationship between metastatic lung disease and LMD.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Kontani K, Hashimoto S, Murazawa C, Norimura S, Tanaka H, Ohtani M, Fujiwara-Honjo N, Date M, Teramoto K, Houchi H, Yokomise H (2014) Factors responsible for long-term survival in metastatic breast cancer. World J Surg Oncol 12:344. doi:10.1186/1477-7819-12-344

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77(3):655–661. doi:10.1016/j.ijrobp.2009.08.025

    Article  PubMed  Google Scholar 

  3. O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55(5):1169–1176

    Article  PubMed  Google Scholar 

  4. Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V (2004) Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al.] 180(5):263–267. doi:10.1007/s00066-004-1180-y

    Article  Google Scholar 

  5. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672. doi:10.1016/s0140-6736(04)16250-8

    Article  PubMed  Google Scholar 

  6. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. doi:10.1016/S1470-2045(09)70263-3

    Article  PubMed  Google Scholar 

  7. Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD (2014) Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neuro-Oncol 120(1):163–169. doi:10.1007/s11060-014-1539-6

    Article  Google Scholar 

  8. Atalar B, Modlin LA, Choi CY, Adler JR, Gibbs IC, Chang SD, Harsh GR, Li G, Nagpal S, Hanlon A, Soltys SG (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713–718. doi:10.1016/j.ijrobp.2013.07.034

    Article  PubMed  Google Scholar 

  9. Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD (2008) Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 108(2):248–257. doi:10.3171/jns/2008/108/2/0248

    Article  PubMed  Google Scholar 

  10. Jo KI, Lim DH, Kim ST, Im YS, Kong DS, Seol HJ, Nam DH, Lee JI (2012) Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery. J Neuro-Oncol 109(2):293–299. doi:10.1007/s11060-012-0892-6

    Article  Google Scholar 

  11. de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, de Azevedo Pereira AE, Fanelli MF, Gimenes DL (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neuro-Oncol 104(2):565–572. doi:10.1007/s11060-010-0524-y

    Article  Google Scholar 

  12. Meattini I, Livi L, Saieva C, Franceschini D, Marrazzo L, Greto D, Scotti V, Scoccianti S, Paiar F, Bordi L, Nori J, Sanchez L, Orzalesi L, Bianchi S, Biti G (2012) Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience. J Chemother (Florence, Italy) 24(5):279–284. doi:10.1179/1973947812y.0000000034

    Article  Google Scholar 

  13. Xu Z, Schlesinger D, Toulmin S, Rich T, Sheehan J (2012) Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. Int J Radiat Oncol Biol Phys 84(3):612–618. doi:10.1016/j.ijrobp.2011.12.054

    Article  PubMed  Google Scholar 

  14. Torrejon D, Oliveira M, Cortes J, Sanchez-Olle G, Gomez P, Bellet M, Saura C, Peg V, Rovira A, Di Cosimo S (2013) Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis. Breast (Edinburgh, Scotland) 22(1):19–23. doi:10.1016/j.breast.2012.10.009

    Article  Google Scholar 

  15. Siomin VE, Vogelbaum MA, Kanner AA, Lee SY, Suh JH, Barnett GH (2004) Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. J Neuro-Oncol 67(1–2):115–121

    Article  Google Scholar 

  16. Ojerholm E, Lee JY, Thawani JP, Miller D, O’Rourke DM, Dorsey JF, Geiger GA, Nagda S, Kolker JD, Lustig RA, Alonso-Basanta M (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121(Suppl):75–83. doi:10.3171/2014.6.gks14708

    PubMed  Google Scholar 

  17. Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD (2014) Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Paper presented at the American Society for Radiation Oncology Annual Meeting, San Francisco, CA

  18. Tallet AV, Azria D, Le Rhun E, Barlesi F, Carpentier AF, Goncalves A, Taillibert S, Dhermain F, Spano JP, Metellus P (2014) Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer. Int J Mol Sci 15(5):8138–8152. doi:10.3390/ijms15058138

    Article  PubMed  PubMed Central  Google Scholar 

  19. Le Rhun E, Taillibert S, Devos P, Zairi F, Turpin A, Rodrigues I, Cazin JL, Pierret MF, Andre C, Dubois F, Bonneterre J, Chamberlain MC (2013) Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series. Anti-Cancer Drugs 24(10):1093–1097. doi:10.1097/cad.0000000000000010

    Article  PubMed  Google Scholar 

  20. Le Rhun E, Taillibert S, Zairi F, Pannier D, Boulanger T, Andre C, Cazin JL, Dubois F, Bonneterre J, Chamberlain MC (2013) Prolonged survival of patients with breast cancer-related leptomeningeal metastases. Anticancer Res 33(5):2057–2063

    PubMed  Google Scholar 

  21. Clarke JL (2012) Leptomeningeal metastasis from systemic cancer. Continuum (Minneap Minn) 18(2):328–342. doi:10.1212/01.CON.0000413661.58045.e7

    Google Scholar 

  22. Pauls S, Fischer AC, Brambs HJ, Fetscher S, Hoche W, Bommer M (2012) Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors. Eur J Radiol 81(5):974–978. doi:10.1016/j.ejrad.2011.02.020

    Article  PubMed  Google Scholar 

  23. An YJ, Cho HR, Kim TM, Keam B, Kim JW, Wen H, Park CK, Lee SH, Im SA, Kim JE, Choi SH, Park S (2015) An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int J Cancer 136(1):162–171. doi:10.1002/ijc.28949

    CAS  Article  PubMed  Google Scholar 

  24. Wang P, Piao Y, Zhang X, Li W, Hao X (2013) The concentration of CYFRA 21–1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Cancer Biomark 13(2):123–130. doi:10.3233/cbm-130338

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Radiation Oncology, University of Virginia Health System, P.O. Box 800383, Charlottesville, VA, 22908, USA

    Daniel M. Trifiletti, Kara D. Romano, Kelli A. Reardon & Jason Sheehan

  2. Department of Neurological Surgery, University of Virginia, Charlottesville, VA, USA

    Zhiyuan Xu & Jason Sheehan

Authors
  1. Daniel M. Trifiletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kara D. Romano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhiyuan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kelli A. Reardon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jason Sheehan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel M. Trifiletti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Trifiletti, D.M., Romano, K.D., Xu, Z. et al. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer. J Neurooncol 124, 421–427 (2015). https://doi.org/10.1007/s11060-015-1854-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-1854-6

Keywords

  • Leptomeningeal disease
  • Breast cancer
  • Brain metastases
  • Radiosurgery